2013 Investors :

Amgen Ventures, Thousand Oaks, CA
Aphelion Capital, Mill Valley, CA
BioGenerator, St. Louis, MO
Boulder Ventures, Boulder, CO
Charter Life Sciences, Santa Clara, CA
Covidien, Mansfield, MA
CSU Ventures, Fort Collins, CO
Epic Ventures, Albuquerque, NM 
GE Healthcare Financial Services, Chicago, IL
Goodworks Ventures, MT 
High Country Venture, Boulder, CO
Johnson & Johnson Development Corporation, New Brunswick, NJ
Level 5 Partners, Fort Collins, CO
Lightstone Ventures, Boulder, CO 
Mercury Fund, Houston, TX
Mile High Fund, Denver, CO
Morgenthaler Ventures, Menlo Park, CA
New Enterprise Associates, Menlo Park, CA
Novartis Venture Funds, Cambridge, MA
Red Script Ventures, New Brunswick, NJ 
Remeditex, Dallas, TX
Salt Lake Life Science Angels, Salt Lake City, UT
Sanderling Ventures, San Mateo, CA
Signal Peak Ventures, Salt Lake City, UT
Split Rock Partners, Menlo Park, CA
SR One, VC Arm of GlaxoSmithKline, San Francisco, CA 
Technology Partners, Palo Alto, CA
Volcano Capital, New York, NY
Wayne Brown Institute, Salt Lake City, UT
Wexford Capital LP, Greenwich, CT